loadpatents
name:-0.022610902786255
name:-0.01322603225708
name:-0.0007171630859375
Belanger; David B. Patent Filings

Belanger; David B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Belanger; David B..The latest application filed is for "cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators".

Company Profile
0.13.19
  • Belanger; David B. - Lexington MA US
  • BELANGER; David B. - Cambridge MA US
  • Belanger; David B. - Cambrigde MA
  • Belanger, David B. - Fort Worth TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Grant 9,957,254 - Adams , et al. May 1, 2
2018-05-01
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Grant 9,765,067 - Adams , et al. September 19, 2
2017-09-19
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20170197941 - ADAMS; Christopher M. ;   et al.
2017-07-13
Thiophen-2-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic Acid Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators
App 20170197950 - ADAMS; Christopher M. ;   et al.
2017-07-13
Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof
App 20160145247 - Belanger; David ;   et al.
2016-05-26
Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
Grant 9,227,971 - Siddiqui , et al. January 5, 2
2016-01-05
Antimicrobial Carboline Compounds
App 20130116219 - Ellis; David Archer ;   et al.
2013-05-09
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
App 20120322791 - Siddiqui; M. Arshad ;   et al.
2012-12-20
Substituted pyridines that are JNK inhibitors
Grant 8,278,337 - Belanger , et al. October 2, 2
2012-10-02
Novel Jnk Inhibitors
App 20100298314 - Reddy; Panduranga Adulla P. ;   et al.
2010-11-25
Novel Jnk Inhibitors
App 20100179141 - Belanger; David B. ;   et al.
2010-07-15
Compounds For The Treatment Of Inflammatory Disorders
App 20100145048 - Guo; Zhuyan ;   et al.
2010-06-10
Compounds for the treatment of inflammatory disorders
Grant 7,652,020 - Guo , et al. January 26, 2
2010-01-26
Imidazopyrazines as cyclin dependent kinase inhibitors
Grant 7,576,085 - Guzi , et al. August 18, 2
2009-08-18
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
Grant 7,563,798 - Guzi , et al. July 21, 2
2009-07-21
Imidazopyrazines as protein kinase inhibitors
Grant 7,511,040 - Belanger , et al. March 31, 2
2009-03-31
Imidazopyrazines As Protein Kinase Inhibitors
App 20080139571 - Belanger; David B. ;   et al.
2008-06-12
Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis
App 20080119515 - Siddiqui; M Arshad ;   et al.
2008-05-22
Imidazopyrazines as protein kinase inhibitors
App 20070117804 - Zhao; Lianyun ;   et al.
2007-05-24
Methods for inhibiting protein kinases
App 20070105864 - Guzi; Timothy J. ;   et al.
2007-05-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
App 20070072882 - Guzi; Timothy J. ;   et al.
2007-03-29
Compounds for the treatment of inflammatory disorders
App 20060252778 - Guo; Zhuyan ;   et al.
2006-11-09
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
Grant 7,060,728 - Belanger , et al. June 13, 2
2006-06-13
Novel imidazopyrazines as cyclin dependent kinase inhibitors
App 20060106023 - Guzi; Timothy J. ;   et al.
2006-05-18
11,12-Oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
App 20040157805 - Belanger, David B. ;   et al.
2004-08-12
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
Grant 6,750,250 - Belanger , et al. June 15, 2
2004-06-15
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
App 20020037881 - Belanger, David B.
2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed